Atlas Trials

Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy

Clinical trial NCT07436182 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07436182
Sponsor
Mansoura University
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
MitochondriaMetformin
Start date
2026-03-01
Primary completion
2026-06-01
Enrollment
176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.